TKPHF - Takeda Pharmaceutical Company Limited

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2023)Next year (2024)
No. of analysts0088
Avg. Estimate001.461.54
Low estimate001.320.96
High estimate001.583.09
Year ago EPSN/A1.151.031.46
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2023)Next year (2024)
No. of analysts321110
Avg. Estimate7.53M8.22M28.81M27.73M
Low estimate6.68M7.36M28.17M26.56M
High estimate7.08M7.52M29.54M28.73M
Year ago sales5.96M6.36M25.18M28.81M
Sales growth (year/est)26.40%29.30%14.40%-3.70%
Earnings historyInvalid Date29/06/202130/12/202129/06/2022
Est. EPSN/A0.80.650.55
Actual EPSN/A1.150.30.46
DifferenceN/A0.35-0.35-0.09
Surprise %N/A43.70%-53.80%-16.40%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2023)Next year (2024)
Current estimate001.461.54
7 days ago0.361.081.471.58
30 days ago0.361.081.51.49
60 days ago0.361.081.861.52
90 days ago0.361.031.471.48
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A2N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesTKPHFIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year41.70%N/AN/AN/A
Next year5.50%N/AN/AN/A
Next 5 years (per annum)1.10%N/AN/AN/A
Past 5 years (per annum)22.73%N/AN/AN/A